199 related articles for article (PubMed ID: 19478385)
21. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.
Hansen TF; Kjær-Frifeldt S; Lindebjerg J; Rafaelsen SR; Jensen LH; Jakobsen A; Sørensen FB
Acta Oncol; 2018 Apr; 57(4):528-533. PubMed ID: 28980848
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
23. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U
Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
25. High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis.
Isaksson-Mettävainio M; Palmqvist R; Dahlin AM; Van Guelpen B; Rutegård J; Oberg A; Henriksson ML
Int J Cancer; 2012 Aug; 131(4):779-88. PubMed ID: 21964812
[TBL] [Abstract][Full Text] [Related]
26. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.
Mesker WE; Junggeburt JM; Szuhai K; de Heer P; Morreau H; Tanke HJ; Tollenaar RA
Cell Oncol; 2007; 29(5):387-98. PubMed ID: 17726261
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.
den Uil SH; van den Broek E; Coupé VMH; Vellinga TT; Delis-van Diemen PM; Bril H; Belt EJT; Kranenburg O; Stockmann HBAC; Belien JAM; Meijer GA; Fijneman RJA
BMC Gastroenterol; 2019 Aug; 19(1):146. PubMed ID: 31420015
[TBL] [Abstract][Full Text] [Related]
28. SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells.
Pohl M; Radacz Y; Pawlik N; Schoeneck A; Baldus SE; Munding J; Schmiegel W; Schwarte-Waldhoff I; Reinacher-Schick A
Anticancer Res; 2010 Jul; 30(7):2603-13. PubMed ID: 20682989
[TBL] [Abstract][Full Text] [Related]
29. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
[TBL] [Abstract][Full Text] [Related]
30. Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients.
Wyss J; Dislich B; Koelzer VH; Galván JA; Dawson H; Hädrich M; Inderbitzin D; Lugli A; Zlobec I; Berger MD
Clin Colorectal Cancer; 2019 Mar; 18(1):e20-e38. PubMed ID: 30389315
[TBL] [Abstract][Full Text] [Related]
31. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
33. Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
Ouahoud S; Voorneveld PW; van der Burg LRA; de Jonge-Muller ESM; Schoonderwoerd MJA; Paauwe M; de Vos T; de Wit S; van Pelt GW; Mesker WE; Hawinkels LJAC; Hardwick JCH
Oncogene; 2020 Mar; 39(12):2453-2466. PubMed ID: 31974473
[TBL] [Abstract][Full Text] [Related]
34. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
[TBL] [Abstract][Full Text] [Related]
35. The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers.
Zengin M; Benek S
Pathol Oncol Res; 2020 Oct; 26(4):2755-2764. PubMed ID: 32696416
[TBL] [Abstract][Full Text] [Related]
36. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract][Full Text] [Related]
37. The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
Zong L; Zhang Q; Kong Y; Yang F; Zhou Y; Yu S; Wu M; Chen J; Zhang Y; Xiang Y
Gynecol Oncol; 2020 Mar; 156(3):676-681. PubMed ID: 31882242
[TBL] [Abstract][Full Text] [Related]
38. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.
Du Y; Zhou X; Huang Z; Qiu T; Wang J; Zhu W; Wang T; Liu P
PLoS One; 2014; 9(10):e110182. PubMed ID: 25333693
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study.
Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE
Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
